Outer membrane vesicle vaccines
Outer Membrane Vesicles (OMV) have received increased attention in recent years as a vaccine platform against bacterial pathogens. OMV from Neisseria meningitidis serogroup B have been extensively explored. Following the success of the MeNZB OMV vaccine in controlling an outbreak of N. meningitidis...
主要な著者: | Micoli, F, MacLennan, CA |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2020
|
類似資料
-
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1
著者:: Marini, A, 等
出版事項: (2017) -
Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
著者:: Micoli, F, 等
出版事項: (2018) -
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
著者:: Arianna Marini, 等
出版事項: (2017-01-01) -
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
著者:: Francesca Micoli, 等
出版事項: (2023-05-01) -
Outer Membrane Vesicles: An Emerging Vaccine Platform
著者:: Dharmendra Kashyap, 等
出版事項: (2022-09-01)